Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 8/20 | 0.39 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 5/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CTSD | P07339 | 1/20 | 0.34 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.33 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6942603 | 1.00 | BACE1 (0.39) | BACE1HCAR3HCAR2CNR1ALDH1A1 | |
| SCHEMBL7862053 | 1.00 | BACE1 (0.39) | BACE1HCAR3HCAR2CNR1ALDH1A1 | |
| SCHEMBL9005074 | 0.86 | HSD11B1 (0.38) | BACE1HCAR3HCAR2CNR1ALDH1A1 | |
| SCHEMBL8723263 | 0.86 | HSD11B1 (0.38) | BACE1HCAR3HCAR2CNR1ALDH1A1 | |
| SCHEMBL19904901 | 0.84 | BACE1 (0.38) | BACE1HCAR3HCAR2CNR1ALDH1A1 | |
| SCHEMBL6151991 | 0.82 | BACE1 (0.35) | BACE1HCAR3HCAR2CNR1ALDH1A1 | |
| SCHEMBL18757708 | 0.80 | PDE2A (0.39) | — | |
| SCHEMBL8805782 | 0.79 | BACE1 (0.38) | BACE1HCAR3HCAR2ALDH1A1CTSD | |
| SCHEMBL8446160 | 0.77 | NPSR1 (0.44) | HCAR3HCAR2CNR1ALDH1A1 | |
| SCHEMBL20970626 | 0.77 | ALDH1A1 (0.38) | BACE1HCAR3HCAR2CNR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0618198-B1 | Process for the preparation of derivatives of 1-(1,2,4-triazol-1-yl)-propan-2-ol | TEVA PHARMA (IL) | 2000-05-03 | — | — | EP | disclosed |
| EP-0618198-A1 | Process for the preparation of 1,3-bis (1,2,4-triazol-1-yl)-propan-2-ol derivatives | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 1994-10-05 | — | — | EP | disclosed |